Adediran S A, Cabaret D, Flavell R R, Sammons J A, Wakselman M, Pratt R F
Department of Chemistry, Wesleyan University, Middletown, CT 06459, USA.
Bioorg Med Chem. 2006 Oct 15;14(20):7023-33. doi: 10.1016/j.bmc.2006.06.023. Epub 2006 Jun 27.
Beta-lactams with 6alpha (penicillins) or 7alpha (cephalosporins) substituents are often beta-lactamase inhibitors. This paper assesses the effect of such substituents on acyclic beta-lactamase substrates. Thus, a series of m-carboxyphenyl phenaceturates, substituted at the glycyl alpha-carbon by -OMe, -CH(2)OH, -CO(2)(-), and -CH(2)NH(3)(+), have been prepared, and tested for their reactivity against serine beta-lactamases. The latter two are novel substituents in beta-lactamase substrates. The methoxy and hydroxymethyl compounds were found to be poor to moderately good substrates, depending on the enzyme. The aminomethyl compound gave rise to a transiently stable (t(1/2)=4.6s) complex on its reaction with a class C beta-lactamase. The reactivity of the compounds against three low molecular weight DD-peptidases was also tested. Again, the methoxy and hydroxymethyl compounds proved to be quite good substrates with no sign of inhibitory complexes. The DD-peptidases reacted with one enantiomer (the compounds were prepared as racemates), presumably the D compound. The class C beta-lactamase reacted with both D and L enantiomers although it preferred the latter. The structural bases of these stereo-preferences were explored by reference to the crystal structure of the enzyme by molecular modeling studies. The aminomethyl compound was unreactive with the DD-peptidases, whereas the carboxy compound did not react with any of the above-mentioned enzymes. The inhibitory effects of the -OMe and -CH(2)OH substituents in beta-lactams apparently require a combination of the substituent and the pendant leaving group of the beta-lactam at the acyl-enzyme stage.
具有6α(青霉素类)或7α(头孢菌素类)取代基的β-内酰胺类药物通常是β-内酰胺酶抑制剂。本文评估了此类取代基对无环β-内酰胺酶底物的影响。因此,已制备了一系列间羧基苯基苯乙酰脲类化合物,它们在甘氨酰α-碳上被-OMe、-CH(2)OH、-CO(2)(-)和-CH(2)NH(3)(+)取代,并测试了它们对丝氨酸β-内酰胺酶的反应活性。后两者是β-内酰胺酶底物中的新型取代基。根据所使用的酶不同,甲氧基和羟甲基化合物被发现是较差至中等良好的底物。氨基甲基化合物在与C类β-内酰胺酶反应时会形成一种短暂稳定的(t(1/2)=4.6秒)复合物。还测试了这些化合物对三种低分子量DD-肽酶的反应活性。同样,甲氧基和羟甲基化合物被证明是相当好的底物,没有抑制性复合物的迹象。DD-肽酶与一种对映体(这些化合物是以外消旋体形式制备的)反应,大概是D型化合物。C类β-内酰胺酶与D型和L型对映体都反应,尽管它更喜欢后者。通过分子模拟研究参考酶的晶体结构,探索了这些立体选择性的结构基础。氨基甲基化合物与DD-肽酶无反应,而羧基化合物与上述任何一种酶都不反应。β-内酰胺中-OMe和-CH(2)OH取代基的抑制作用显然需要在酰基酶阶段,取代基与β-内酰胺的侧链离去基团相结合。